Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01675349Phase 2Completed
A Phase 2 trial of chenopodium album allergen extract in Chenopodium album allergy, sponsored by LETI Pharma. Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01675349.